Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Open accessThe DOI matches its Crossref record; 159 of the 160 references it cites were found in a registry or an index.
Abstract
Some tissue types give rise to human cancers millions of times more often than other tissue types. Although this has been recognized for more than a century, it has never been explained. Here, we show that the lifetime risk of cancers of many different types is strongly correlated (0.81) with the total number of divisions of the normal self-renewing cells maintaining that tissue's homeostasis. These results suggest that only a third of the variation in cancer risk among tissues is attributable to environmental factors or inherited predispositions. The majority is due to "bad luck," that is, random mutations arising during DNA replication in normal, noncancerous stem cells. This is important not only for understanding the disease but also for designing strategies to limit the mortality it causes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cancer formation is the result of the stochastic intracellular accumulation of spontaneous mutations during DNA replication, combined with the environment exposure and lifestyle habits, both able to significantly influence cancer risk [3,4].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Self-citationOstrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Self-citationMutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Simplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Cited by
Items 401–500 of 1,001
Is Bad Luck the Main Cause of Cancer?
Weinberg, C. R., & Zaykin, D. V. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv125 · Cited by 52
Thomas, P. D., & Kahn, M. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9318-0 · Cited by 52
“lation between the total number of divisions of normal SSC populations and the total lifetime risk of developing cancer in a particular tissue (Tomasetti and Vogelstein 2015).”
InfluentialBiomarkers and Immunotherapeutic Targets in Glioblastoma
Hung, A. L., Garzón-Muvdi, T., & Lim, M. K. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.03.011 · Cited by 53
Daigh, L. H., Liu, C., Chung, M., Cimprich, K. A., & Meyer, T. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.011 · Cited by 52
“Stochastic damage events that occur during DNA replication have been proposed to be the predominant source of cancer-causing mutations (Tomasetti et al., 2017; Tomasetti and Vogelstein, 2015).”
BackgroundInnate Sensing through Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis
Koliaraki, V., Chalkidi, N., Henriques, A. R., Tzaferis, C., Polykratis, A., Waisman, A., Müller, W., Hackam, D. J., Pasparakis, M., & Kollias, G. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.072 · Cited by 52
Regulation of Latency in the Human T Cell Leukemia Virus, HTLV-1
Bangham, C. R. M., Miura, M., Kulkarni, A., & Matsuoka, M. (2019) · Annual Review of Virology · doi:10.1146/annurev-virology-092818-015501 · Cited by 52
“It is likely that most such mutations arise through constant cell division in the long-lived HTLV-1-infected T cell clones (130, 131).”
BackgroundZefferino, R., Piccoli, C., Gioia, S. D., Capitanio, N., & Conese, M. (2019) · Cells · doi:10.3390/cells8080896 · Cited by 52
Li, C., & Luscombe, N. M. (2020) · Nature Communications · doi:10.1038/s41467-020-15185-0 · Cited by 52
Why do young people get cancer?
Kentsis, A. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28335 · Cited by 52
Nunney, L., & Muir, B. M. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0161 · Cited by 52
López‐Lázaro, M. (2015) · Oncoscience · doi:10.18632/oncoscience.159 · Cited by 51
Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer
Rajput, A., Bocklage, T. J., Greenbaum, A. A., Lee, J., & Ness, S. A. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.11.004 · Cited by 51
“These results fit with models of colon cancer carcinogenesis that predict the involvement of a limited number of driver mutations involved in the development of the primary tumor.(16,17) Thus, the mutational spectrum observed in colon carcinoma, even in this small cohort of samples, was quite diverse.”
Härtung, T. (2017) · ALTEX · doi:10.14573/altex.1707011 · Cited by 51
The Metabolic Interplay between Cancer and Other Diseases
Le, A., Udupa, S., & Zhang, C. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.10.012 · Cited by 51
“In addition to the increase in the acquisition of somatic nuclear mutations as age progresses [98], metabolism also changes dramatically with age.”
BackgroundIlan, Y., & Spigelman, Z. S. (2020) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100240 · Cited by 51
An emerging role for cellular crosstalk in the cancer stem cell niche
Oshimori, N., Guo, Y., & Taniguchi, S. (2021) · The Journal of Pathology · doi:10.1002/path.5655 · Cited by 51
Chibuk, J., Flory, A., Kruglyak, K. M., Leibman, N. F., Nahama, A., Dharajiya, N. G., van den Boom, D., Jensen, T. J., Friedman, J. S., Shen, M. R., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.664718 · Cited by 52
Environmental exposure to human carcinogens in teenagers and the association with DNA damage
Franken, C., Koppen, G., Lambrechts, N., Govarts, E., Bruckers, L. M., Hond, E. D., Loots, I., Nelen, V., Sioen, I., Nawrot, T. S., et al. (2016) · Environmental Research · doi:10.1016/j.envres.2016.10.012 · Cited by 51
Germline Variants That Affect Tumor Progression
Chatrath, A., Ratan, A., & Dutta, A. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.10.005 · Cited by 50
Changes of telomere status with aging: An update
Ishikawa, N., Nakamura, K., Izumiyama‐Shimomura, N., Aida, J., Matsuda, Y., Arai, T., & Takubo, K. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12772 · Cited by 50
Interleukin-8 in the Tumor Immune Niche: Lessons from Comparative Oncology
Kim, J. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38315-2_2 · Cited by 51
Nutritional Control of Intestinal Stem Cells in Homeostasis and Tumorigenesis
Calibasi‐Kocal, G., Mashinchian, O., Başbınar, Y., Ellidokuz, E., Cheng, C., & Yilmaz, Ö. H. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.11.003 · Cited by 51
Palmer, S., Cunniffe, N. J., & Donnelly, R. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0982 · Cited by 50
A local mechanism by which alcohol consumption causes cancer
López‐Lázaro, M. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.10.001 · Cited by 50
Stem cell mutations, associated cancer risk, and consequences for regenerative medicine
Derks, L. L. M., & van Boxtel, R. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.09.008 · Cited by 49
On the apparent rarity of epithelial cancers in captive chimpanzees
Varki, N. M., & Varki, A. P. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0225 · Cited by 50
“the suggestion that the majority of cancers result from ‘bad luck’—random mutations arising during DNA replication in normal, noncancerous stem cells [10].”
BackgroundClewell, R. A., Thompson, C. M., & M.A., H. J. C. I. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.025 · Cited by 49
Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells
Hu, W., Lu, R., Hu, D., Imir, O. B., Zuo, Q., Moline, D., Afradiasbagharani, P., Liu, L., Lowe, S., Birch, L. A., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114902 · Cited by 48
Neferine suppresses diethylnitrosamine-induced lung carcinogenesis in Wistar rats
Sivalingam, K., Vinoth, A., Ganasan, K., Huang, C., & Viswanadha, V. P. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.014 · Cited by 48
Somatic Variants: New Kids on the Block in Human Immunogenetics
Horebeek, L. V., Dubois, B., & Goris, A. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.09.005 · Cited by 48
Burge, R. A., & Hobbs, G. A. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.004 · Cited by 48
The H3K27M mutation alters stem cell growth, epigenetic regulation, and differentiation potential
Kfoury, N., Prakasam, R., Pondugula, S., Lagas, J. S., Matkovich, S. J., Gontarz, P. M., Yang, L., Yano, H., Kim, A. H., Rubin, J. B., et al. (2022) · BMC Biology · doi:10.1186/s12915-022-01324-0 · Cited by 48
“It is widely recognized that cancer risk is relatable to stem cell activity and proliferation [21].”
BackgroundA Critical Examination of the “Bad Luck” Explanation of Cancer Risk
Rozhok, A. I., Wahl, G. M., & DeGregori, J. V. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0229 · Cited by 47
“Tomasetti and Vogelstein propose that the critical factor linkingmutations and cancer is the cumulative number of divisions that tissue-restricted stem cells undergo.”
InfluentialPerspectives on making big data analytics work for oncology
Naqa, I. E. (2016) · Methods · doi:10.1016/j.ymeth.2016.08.010 · Cited by 47
Reher, D., Klink, B., Deutsch, A., & Voß-Böhme, A. (2017) · Biology Direct · doi:10.1186/s13062-017-0188-z · Cited by 47
“To relax the model assumption of non-dividing cells, however, would be of interest, given that the number of stem cell divisions strongly correlates with cancer risk over various tissues [60, 61], and that heterogeneity in cell division rates could also have great impact on tumour cell composition and therefore cell d…”
BackgroundCancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance
Hoque, S., Dhar, R., Kar, R., Mukherjee, S., Mukherjee, D., Mukerjee, N., Nag, S., Tomar, N., & Mallik, S. (2023) · Biomarkers · doi:10.1080/1354750x.2022.2157875 · Cited by 47
HTLV-1 drives vigorous clonal expansion of infected CD8+ T cells in natural infection
Melamed, A., Laydon, D. J., Al-Khatib, H. A., Rowan, A. G., Taylor, G. P., & Bangham, C. R. M. (2015) · Retrovirology · doi:10.1186/s12977-015-0221-1 · Cited by 48
Cancer killers in the human gut microbiota: diverse phylogeny and broad spectra
Zhou, Y., Zhao, D., Liu, H., Chen, H., Li, J., Mu, X., Liu, Z., Li, X., Tang, L. M., Zhao, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17319 · Cited by 47
Evaluating biomarkers to model cancer risk post cosmic ray exposure
Sridharan, D. M., Asaithamby, A., Blattnig, S. R., Costes, S. V., Doetsch, P. W., Dynan, W. S., Hahnfeldt, P., Hlatky, L., Kidane, Y., Kronenberg, A., et al. (2016) · Life Sciences in Space Research · doi:10.1016/j.lssr.2016.05.004 · Cited by 46
Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance
Nairuz, T., Mahmud, Z., Manik, M. R. K., & Kabir, Y. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10529-x · Cited by 46
Zhang, W., Edwards, A., Flemington, E. K., & Zhang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13091-y · Cited by 46
Zhang, R., Li, H., Zhang, S., Zhang, Y., Wang, N., Zhou, H., He, H., Hu, G., Zhang, T., & Ma, W. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0610-1 · Cited by 46
Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis
Henriques, A. R., Koliaraki, V., & Kollias, G. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805683115 · Cited by 46
Forman, D., Bauld, L., Bonanni, B., Brenner, H., Brown, K., Dillner, J., Kampman, E., Mańczuk, M., Ríboli, E., Steindorf, K., et al. (2018) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2018.07.001 · Cited by 46
“Although estimates on the overall preventability of cancer vary [5, 6], there is broad agreement that the proportion of cancers that could be prevented on the basis of current knowledge would be around 30-40% in westernised countries - if current understanding of risk and protective factors was translated into effecti…”
BackgroundResveratrol and its Related Polyphenols Contribute to the Maintenance of Genome Stability
Matsuno, Y., Atsumi, Y., Alauddin, M., Rana, M. M., Fujimori, H., Hyodo, M., Shimizu, A., Ikuta, T., Tani, H., Torigoe, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62292-5 · Cited by 46
Targeting prion protein interactions in cancer
Santos, T. G., Lopes, M. H., & Martins, V. R. (2015) · Prion · doi:10.1080/19336896.2015.1027855 · Cited by 46
Montales, M. T. E., Simmen, R. C. M., Ferreira, E. D. S., Neves, V. A., & Simmen, F. A. (2015) · Genes & Nutrition · doi:10.1007/s12263-015-0499-6 · Cited by 46
Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue
Kuijk, E., Kranenburg, O., Cuppen, E. P. J. G., & van Hoeck, A. (2022) · Nature Communications · doi:10.1038/s41467-022-33663-5 · Cited by 45
An immunogenetic basis for lung cancer risk
Krishna, C., Tervi, A. M., Saffern, M., Wilson, E. A., Yoo, S., Mars, N., Roudko, V., Cho, B. A., Jones, S. E., Vaninov, N., et al. (2024) · Science · doi:10.1126/science.adi3808 · Cited by 47
“We propose that the immune sys-tem, consisting of immunogenetic and cellular diversity, comprises the foundation of tumor rejection and initiation ( 12 – 16 ), together with replicative and hereditary defects and environmental exposures as proposed by Tomasetti and Vogelstein ( 91 , 92 ).”
BackgroundStrategies to Prevent “Bad Luck” in Cancer
Albini, A., Cavuto, S., Apolone, G., & Noonan, D. M. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv213 · Cited by 45
Cofré, J., & Abdelhay, E. S. F. W. (2017) · The Scientific World JOURNAL · doi:10.1155/2017/3578090 · Cited by 45
“In countercurrent with this way of thinking, it is strongly considered that mutations (at random or by chance) [3, 4] or environmental factors inducing mutations are the leading causes of cancer over, for example, environmental factors that can be activating the cell’s normal regulatory mechanisms.”
BackgroundNeuronal Activity-Dependent Control of Postnatal Neurogenesis and Gliogenesis
Káradóttir, R. T., & Kuo, C. T. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031054 · Cited by 45
“…retaining a dedicated stem cell population requires extra energy and resources, and when they acquire oncogenic mutations over time, these proliferative cells can become tumorigenic (Alcantara Llaguno et al. 2009), leading to harmful sequelae to the host tissue (Tomasetti & Vogelstein 2015).”
Han, H., Davidson, L. A., Fan, Y., Goldsby, J. S., Yoon, G., Jin, U., Wright, G. A., Landrock, K. K., Weeks, B. R., Wright, R. C., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104319 · Cited by 45
“This is noteworthy, because the life-time risk of cancer is strongly correlated with the total number of stem cell divisions (Tomasetti & Vogelstein, 2015).”
Oral and oropharyngeal cancer and the role of sexual behaviour: a systematic review
Chancellor, J. A., Ioannides, S. J., & Elwood, M. (2016) · Community Dentistry And Oral Epidemiology · doi:10.1111/cdoe.12255 · Cited by 45
Colorectal cancer initiation: Understanding early-stage disease for intervention
Jiang, C., Zhou, Q., Yi, K., Yuan, Y., & Xie, X. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216831 · Cited by 44
Sei, Y., Feng, J., Samsel, L., White, A. O., Zhao, X., Yun, S., Citrin, D. E., McCoy, J. P., Sundaresan, S., Hayes, M. M., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00036.2018 · Cited by 44
“Recent accumulating evidence suggests that ISCs have tumor-initiating potential and thus play a critical role in tumorigenesis of intestinal tumors as reported for colorectal cancers (7, 30, 39, 52).”
BackgroundAACR Cancer Progress Report 2016
Davidson, N. E., Armstrong, S. A., Coussens, L. M., Cruz-Correa, M. R., DeBerardinis, R. J., Doroshow, J. H., Foti, M., Hwu, P., Kensler, T. W., Morrow, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1993 · Cited by 44
“simplified estimates of the relative contribution of each of the various sources of mutations to developing particular types of cancer are illustrated based on a recent study (23).”
Calabrese, E. J. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110064 · Cited by 44
“In 2015, Tomasetti and Vogelstein [184] published an article in Science concluding that random mutations that occur during DNA replication in normal, noncancerous stem cells account for about 70% of human cancers.”
BackgroundReuniting philosophy and science to advance cancer research
Pradeu, T., Daignan‐Fornier, B., Ewald, A. J., Germain, P., Okasha, S., Plutynski, A., Benzekry, S., Bertolaso, M., Bissell, M. J., Brown, J. S., et al. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12971 · Cited by 44
“For instance, she highlighted that many criticisms were due to a lack of clarity on the part of Tomasetti & Vogelstein (2015), particularly in the use of the concept of ‘luck’.”
BackgroundStrupp, C., Corvaro, M., Cohen, S. M., Corton, J. C., Ogawa, K., Richert, L., & Jacobs, M. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713246 · Cited by 44
“Two further major publications by Tomasetti and colleagues in 2015 [7] and 2017 [8] illustrated once again how the interaction between spontaneous cell proliferation and the effects of the environment on cell proliferation (i.”
BackgroundHang, J., Cai, B., Xue, P., Wang, L., Hu, H. X., Zhou, Y., Ren, S., Wu, J., Zhu, M., Chen, D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143696 · Cited by 44
“Several aspects of risk factors for CRC, including inherited genetic variation [4], lifestyle factors [5,6], comorbidity [7] and the lifetime number of stem cell divisions [8], have been studied on different levels.”
Backgroundvan Gemert, W. A., Lanting, C. I., Goldbohm, R. A., van den Brandt, P. A., Grooters, H. G., Kampman, E., Kiemeney, L. A. L. M., van Leeuwen, F. E., Monninkhof, E. M., de Vries, E., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3447-7 · Cited by 44
Enciso, J., Mayani, H., Mendoza, L., & Pelayo, R. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00349 · Cited by 43
Chance, choice and cause in cancer aetiology: individual and population perspectives
Smith, G. D., Relton, C. L., & Brennan, P. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw224 · Cited by 43
“if individuals are carefully examined at regular intervals, there is an excellent chance that they should be detected at an early stage, when it is curable’,(14) echoing the conclusions drawn eight decades later on the basis of the Tomasetti and Vogelstein paper, regarding the apparent need to divert resources from pr…”
BackgroundThe impact of HTLV-1 on the cellular genome
Cook, L. B. M., Melamed, A., Yaguchi, H., & Bangham, C. R. M. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.07.013 · Cited by 43
Replication stress response in cancer stem cells as a target for chemotherapy
Manic, G., Sistigu, A., Corradi, F., Musella, M., Maria, R. D., & Vitale, I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.003 · Cited by 43
Spontaneous de novo germline mutations in humans and mice: rates, spectra, causes and consequences
Ohno, M. (2018) · Genes & Genetic Systems · doi:10.1266/ggs.18-00015 · Cited by 43
Modulation of Anti-Tumour Immune Responses by Probiotic Bacteria
Aindelis, G., & Chlichlia, K. (2020) · Vaccines · doi:10.3390/vaccines8020329 · Cited by 43
Wei, C., Wang, Q., & Liu, C. (2020) · Wireless Communications and Mobile Computing · doi:10.1155/2020/8877625 · Cited by 43
“In the rush hour, the hotel has a daily booking capacity of several hundred thousand and, at the same time, produces massive tourism data such as information collection, consumer reviews, and product recommendations [7].”
BackgroundThe Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time
Huber, A. R., van Hoeck, A., & van Boxtel, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760039 · Cited by 43
“This notion potentially explains why aging is the main risk factor for developing cancer (Edwards et al., 2002; Tomasetti and Vogelstein, 2015).”
BackgroundSMT or TOFT? How the Two Main Theories of Carcinogenesis are Made (Artificially) Incompatible
Bedessem, B., & Ruphy, S. (2015) · Acta Biotheoretica · doi:10.1007/s10441-015-9252-1 · Cited by 44
Evolutionary Ecology of Organs: A Missing Link in Cancer Development?
Thomas, F., Nesse, R. M., Gatenby, R. A., Gidoin, C., Renaud, F., Roche, B., & Újvári, B. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.06.009 · Cited by 43
Dunaway, S., Rothaus, A., Zhang, Y., Kadekaro, A. L., Andl, T., & Andl, C. D. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0061-2 · Cited by 42
Engström, W., Darbre, P. D., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, J. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv030 · Cited by 42
Perturbations in the Replication Program Contribute to Genomic Instability in Cancer
Blumenfeld, B., Ben‐Zimra, M., & Simon, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061138 · Cited by 42
Hiltunen, M., Grudzinska‐Sterno, M., Wallerman, O., Ryberg, M. K., & Johannesson, H. (2019) · Current Biology · doi:10.1016/j.cub.2019.07.025 · Cited by 42
Si, S., Tewara, M. A., Ji, X., Wang, Y., Liu, Y., Dai, X., Wang, Z., & Xue, F. (2020) · Cancer Medicine · doi:10.1002/cam4.3076 · Cited by 42
Comparative Oncology: New Insights into an Ancient Disease
Boddy, A. M., Harrison, T. M., & Abegglen, L. M. (2020) · iScience · doi:10.1016/j.isci.2020.101373 · Cited by 42
Anghileri, E., Ianni, N. D., Paterra, R., Langella, T., Zhao, J., Eoli, M., Patanè, M., Pollo, B., Cuccarini, V., Iavarone, A., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02769-4 · Cited by 42
Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility
Prins, G. S., Calderon-Gierszal, E. L., & Hu, W.-Y. (2015) · Endocrinology · doi:10.1210/en.2015-1357 · Cited by 42
Stangis, M. M., Chen, Z., Min, J., Glass, S. E., Jackson, J. O., Radyk, M. D., Hoi, X. P., Brennen, W. N., Yu, M., Dinh, H. Q., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1550 · Cited by 42
Somatic mutation rates scale with time not growth rate in long-lived tropical trees
Satake, A., Imai, R., Fujino, T., Tomimoto, S., Ohta, K., Na’iem, M., Indrioko, S., Widiyatno, W., Purnomo, S., Mollá‐Morales, A., et al. (2023) · eLife · doi:10.7554/elife.88456.3 · Cited by 41
Transmissible cancers in an evolutionary context
Újvári, B., Papenfuss, A. T., & Belov, K. (2016) · BioEssays · doi:10.1002/bies.201670904 · Cited by 41
Sahakyan, A. B., & Balasubramanian, S. (2016) · BMC Genomics · doi:10.1186/s12864-016-2582-9 · Cited by 41
“Sixty-five percent of variation in the risk of cancer was shown to be explained by the number of cell divisions alone [1], with the heritable component explaining only up to 10 % of variation [2, 3].”
The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
Fonseca, N. A., Cruz, A. F., Moura, V., Simões, S., & Moreira, J. N. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.016 · Cited by 41
Zhang, M., Wang, L., An, K., Cai, J., Li, G., Yang, C., Liu, H., Du, F., Han, X., Zhang, Z., et al. (2018) · Cancer Communications · doi:10.1186/s40880-018-0313-0 · Cited by 38
DNA methylation and histone variants in aging and cancer
Mangelinck, A., & Mann, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.06.002 · Cited by 41
Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up
Li, J., Yung, J., Qiao, B., Takemoto, E. E., Goldfarb, D. G., Zeig‐Owens, R., Cone, J. E., Brackbill, R. M., Farfel, M. R., Kahn, A. R., et al. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab165 · Cited by 41
“exposure and incidence that vary across tumor type (38), all of”
BackgroundThe evolution of powerful yet perilous immune systems
Graham, A. L., Schrom, E. C., & Metcalf, C. J. E. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.12.002 · Cited by 41
“X-chromosome inactivation: a mechanism whereby female mammals shut down one X chromosome in all cells except eggs, leading to equal expression of X chromosome gene human tissues in risk of cancer [22]).”
BackgroundCurrent understanding concerning intestinal stem cells
Cui, S., & Chang, P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i31.7099 · Cited by 41
The relevance of experimental carcinogenicity studies to human safety
Cohen, S. M. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.04.002 · Cited by 41
Yuan, J., Beckman, K. B., Wang, R., Bull, C. F., Adams‐Haduch, J. M., Huang, J. Y., Jin, A., Opresko, P. L., Newman, A. B., Zheng, Y., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31251 · Cited by 41
Vicent, S., Lieshout, R., Saborowski, A. L., Verstegen, M. M. A., Raggi, C., Recalcati, S., Invernizzi, P., van der Laan, L. J. W., Alvaro, D., Calvisi, D. F., et al. (2019) · Liver International · doi:10.1111/liv.14094 · Cited by 41
Clinical and Therapeutic Implications of Cancer Stem Cells
Shin, S. W. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1908886 · Cited by 41
Mechanosensitive hormone signaling promotes mammary progenitor expansion and breast cancer risk
Northey, J. J., Hayward, M.-K., Yui, Y., Stashko, C., Kai, F., Mouw, J. K., Thakar, D., Lakins, J. N., Ironside, A. J., Samson, S. M., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2023.12.002 · Cited by 41
Zhang, Y., Wang, C., & Li, J. J. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00532-4 · Cited by 41
“With this hypothesis, MSCs are assumed to be the original cellular resources holding the pre-cancerous trends when a certain level of cancer hallmark gene mutation is achieved through accumulated cell division times [26, 27].”
BackgroundDivision-independent differentiation mandates proliferative competition among stem cells
Reilein, A. R., Melamed, D., Tavaré, S., & Kalderon, D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718646115 · Cited by 40
“The longevity and proliferative potential of stem cells make it inevitable that the first driver mutations sometimes arise in stem cells, especially for tissues with very active stem cells and short-lived derivatives (1, 4-6).”
BackgroundDeveau, P., Daage, L. C., Oldridge, D. A., Bernard, V., Bellini, A., Chicard, M., Clément, N., Lapouble, E., Combaret, V., Boland, A., et al. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty016 · Cited by 40
“Previous studies have shown that the number of variants was linked to the number of divisions a cell undergoes (Tomasetti and Vogelstein, 2015).”
BackgroundNarbonne, P., Maddox, P. S., & Labbé, J.-C. (2015) · Development · doi:10.1242/dev.130252 · Cited by 40
“Some tissues, such as the gastrointestinal epithelium, have a rapid cellular turnover rate and, accordingly, their stem cells self-renew and differentiate more frequently than those of tissues that turnover more slowly, such as the bone (Tomasetti and Vogelstein, 2015).”
BackgroundDistinct mutation accumulation rates among tissues determine the variation in cancer risk
Hao, D., Wang, L., & Di, L. (2016) · Scientific Reports · doi:10.1038/srep19458 · Cited by 40
Metadata
- Authors
- Tomasetti, C., & Vogelstein, B.
- Affiliations
- Johns Hopkins University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Tomasetti, Cristian
- Vogelstein, Bert
- Venue
- Science
- Published
- 2015-01-02
- Volume
- 347
- Issue
- 6217
- Pages
- 78-81
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4446723
- OpenAlex
- W2019078072
- Cited by
- 1,927
- References
- 160
- Citations by year
- 2026: 63 · 2025: 90 · 2024: 121 · 2023: 126 · 2022: 135 · 2021: 141 · 2020: 159 · 2019: 199 · 2018: 197 · 2017: 231 · 2016: 234 · 2015: 228
- FWCI
- 98.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (P30-CA006973, R37-CA43460, RO1-CA57345, P50-CA62924)
- The Virginia and D. K. Ludwig Fund for Cancer Research
- The Lustgarten Foundation for Pancreatic Cancer Research
- The Sol Goldman Center for Pancreatic Cancer Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- cancer risk, stem cell division, random mutation, DNA replication errors, bad luck hypothesis, cancer mortality, tissue homeostasis
- MeSH terms
- Cell Division, Humans, Mutation, Neoplasms, Risk, Stem Cells, Genetic Variation, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.